93 related articles for article (PubMed ID: 19903772)
1. p34SEI-1 inhibits doxorubicin-induced senescence through a pathway mediated by protein kinase C-delta and c-Jun-NH2-kinase 1 activation in human breast cancer MCF7 cells.
Lee SL; Hong SW; Shin JS; Kim JS; Ko SG; Hong NJ; Kim DJ; Lee WJ; Jin DH; Lee MS
Mol Cancer Res; 2009 Nov; 7(11):1845-53. PubMed ID: 19903772
[TBL] [Abstract][Full Text] [Related]
2. p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies.
Hong SW; Kim CJ; Park WS; Shin JS; Lee SD; Ko SG; Jung SI; Park IC; An SK; Lee WK; Lee WJ; Jin DH; Lee MS
Cancer Res; 2009 Feb; 69(3):741-6. PubMed ID: 19176394
[TBL] [Abstract][Full Text] [Related]
3. Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells.
Jung S; Ohk J; Jeong D; Li C; Lee S; Duan J; Kim C; Lim JS; Yang Y; Kim KI; Lee MS
Int J Oncol; 2014 Jul; 45(1):189-96. PubMed ID: 24789658
[TBL] [Abstract][Full Text] [Related]
4. p34 (SEI-1) inhibits ROS-induced cell death through suppression of ASK1.
Hong SW; Shin JS; Lee YM; Kim DG; Lee SY; Yoon DH; Jung SY; Hwang JJ; Lee SJ; Cho DH; Hong YS; Kim TW; Jin DH; Lee WK
Cancer Biol Ther; 2011 Sep; 12(5):421-6. PubMed ID: 21725208
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic function of p34SEI-1 via NEDD4‑1‑mediated PTEN ubiquitination/degradation and activation of the PI3K/AKT pathway.
Jung S; Li C; Jeong D; Lee S; Ohk J; Park M; Han S; Duan J; Kim C; Yang Y; Kim KI; Lim JS; Kang YS; Lee MS
Int J Oncol; 2013 Nov; 43(5):1587-95. PubMed ID: 23970032
[TBL] [Abstract][Full Text] [Related]
6. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
Li J; Melvin WS; Tsai MD; Muscarella P
Biochemistry; 2004 Apr; 43(14):4394-9. PubMed ID: 15065884
[TBL] [Abstract][Full Text] [Related]
7. PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH₂-terminal kinase activation.
Yanase N; Hayashida M; Kanetaka-Naka Y; Hoshika A; Mizuguchi J
BMC Cell Biol; 2012 Mar; 13():7. PubMed ID: 22435755
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
J Cell Physiol; 2018 Mar; 233(3):2526-2536. PubMed ID: 28777435
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
[TBL] [Abstract][Full Text] [Related]
10. Low doses of ionizing radiation suppress doxorubicin-induced senescence-like phenotypes by activation of ERK1/2 and suppression of p38 kinase in MCF7 human breast cancer cells.
Shin JS; Woo SH; Lee HC; Hong SW; Yoo DH; Hong SI; Lee WJ; Lee MS; Jin YW; An S; Jin DH; Park IC
Int J Oncol; 2010 Jun; 36(6):1445-52. PubMed ID: 20428768
[TBL] [Abstract][Full Text] [Related]
11. NMR uncovers direct interaction between human NEDD4-1 and p34
Shrestha P; Yun JH; Ko YJ; Yeon KJ; Kim D; Lee H; Jin DH; Nam KY; Yoo HD; Lee W
Biochem Biophys Res Commun; 2017 Aug; 490(3):984-990. PubMed ID: 28666866
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).
Sugimoto M; Nakamura T; Ohtani N; Hampson L; Hampson IN; Shimamoto A; Furuichi Y; Okumura K; Niwa S; Taya Y; Hara E
Genes Dev; 1999 Nov; 13(22):3027-33. PubMed ID: 10580009
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine-Induced Contraction in the Isolated Endothelium-Denuded Rat Aorta Involves PKC-δ-mediated JNK Phosphorylation.
Yu J; Ok SH; Kim WH; Cho H; Park J; Shin IW; Lee HK; Chung YK; Choi MJ; Kwon SC; Sohn JT
Int J Med Sci; 2015; 12(9):727-36. PubMed ID: 26392810
[TBL] [Abstract][Full Text] [Related]
14. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A).
Li J; Muscarella P; Joo SH; Knobloch TJ; Melvin WS; Weghorst CM; Tsai MD
Biochemistry; 2005 Oct; 44(40):13246-56. PubMed ID: 16201750
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
16. S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells.
Oliva JL; Caino MC; Senderowicz AM; Kazanietz MG
J Biol Chem; 2008 Feb; 283(9):5466-76. PubMed ID: 18162471
[TBL] [Abstract][Full Text] [Related]
17. PKC delta mediates ionizing radiation-induced activation of c-Jun NH(2)-terminal kinase through MKK7 in human thyroid cells.
Mitsutake N; Namba H; Shklyaev SS; Tsukazaki T; Ohtsuru A; Ohba M; Kuroki T; Ayabe H; Yamashita S
Oncogene; 2001 Feb; 20(8):989-96. PubMed ID: 11314034
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
[TBL] [Abstract][Full Text] [Related]
19. N-benzyladriamycin-14-valerate (AD198) induces apoptosis through protein kinase C-delta-induced phosphorylation of phospholipid scramblase 3.
He Y; Liu J; Durrant D; Yang HS; Sweatman T; Lothstein L; Lee RM
Cancer Res; 2005 Nov; 65(21):10016-23. PubMed ID: 16267027
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK
J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
